Find the Right Market Report

Search thousands of industry reports, market insights, and research studies in one place.

Not sure where to start? Try one of these:
Explore healthcare market intelligence and industry insights
Towards Healthcare

Hydrophilic Catheters Companies and Market Forecast

Date : 13 May 2026

Top Companies in the Hydrophilic Catheters Market & Their Offerings

Hydrophilic Catheters Market Companies are BD (C. R. Bard, Inc.), Teleflex Incorporated, B. Braun Melsungen AG, Coloplast A/S, Hollister Incorporated, Arthesys, AngioDynamics, Inc.

Companies Headquarters Offerings
C. R. Bard, Inc. (BD) New Jersey, USA Intermittent hydrophilic catheters, urology devices, and infection-prevention technologies focused on patient safety and ease of use. 
Teleflex Incorporated Pennsylvania, USA Hydrophilic intermittent catheters, urology and critical care devices, emphasizing minimally invasive solutions and improved patient comfort.
B. Braun Melsungen AG Melsungen, Germany Hydrophilic-coated catheters with advanced biocompatible coatings, urology care products, and hospital-based catheter solutions.
Coloplast A/S Humlebæk, Denmark Hydrophilic intermittent catheters (e.g., SpeediCath), continence care products, and home-use catheter solutions with strong patient-centric design.
Hollister Incorporated Illinois, USA Hydrophilic and pre-lubricated catheters, continence care products, and home healthcare solutions focused on comfort and discretion.
Arthesys Barcelona, Spain Specialty hydrophilic-coated catheters and interventional medical devices with a focus on advanced coating technologies.
AngioDynamics, Inc. New York, USA Hydrophilic-coated catheters are mainly used for vascular and interventional procedures, along with minimally invasive medical devices

What are the Recent Developments in the Hydrophilic Catheters Market? 

  • In January 2025, B. Braun Medical Inc. introduced the Clik-FIX Epidural/Peripheral Nerve Block catheter securement device. It is designed to be soft, low-profile, and easy to apply, helping keep catheters firmly in place during procedures. The device reduces the chances of displacement or dislodgement, improving safety and convenience for both patients and healthcare professionals
  • In January 2025, Radical Catheter Technologies received FDA 510(k) clearance for its 8F neurovascular catheter. Built on its patented ribbon technology, the device features a larger inner diameter to support a wider range of treatments. It is designed to offer better flexibility, stability, and durability, helping enable faster procedures while potentially lowering risks and overall treatment costs.

Supply Chain Analysis

R&D

  • R&D in hydrophilic catheters is mainly focused on improving patient comfort, minimizing infection risk, and making catheterization easier through advanced materials and improved coating technologies. Companies are developing smoother, more biocompatible surfaces and user-friendly designs to support safe self-catheterization.
  • Key players: Coloplast, B. Braun, Teleflex, BD, and Hollister Incorporated.

Clinical Trials

  • Clinical trials studies show that hydrophilic catheters help lower the risk of urinary tract infections and offer better comfort than uncoated catheters, mainly by reducing friction during insertion. This leads to smoother, less painful catheterization and improved patient outcomes.
  • Key players: Coloplast, B. Braun, Teleflex, BD, and Hollister Incorporated.

Patient Support and Services

  • Patient support for hydrophilic catheters is centered on helping users manage catheterization independently while lowering the risk of UTIs and reducing urethral injury. This is achieved through proper training, guidance, and access to high-quality, easy-to-use products that ensure safer and more comfortable use.
  • Key players: Coloplast, B. Braun, Teleflex, BD, and Hollister Incorporated.

Market Growth

The global hydrophilic catheters market size was estimated at USD 2.41 billion in 2025 and is predicted to increase from USD 2.6 billion in 2026 to approximately USD 5.13 billion by 2035, expanding at a CAGR of 7.85% from 2026 to 2035. The market is growing steadily due to rising cases of urinary disorders, an increasing elderly population, and higher demand for comfortable, low-friction catheterization solutions. 

Hydrophilic Catheters Market Size is USD 2.6 Billion in 2026.

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.

Talk to an Analyst Contact Sales